Southern fashion isn't just for people south of the Mason-Dixon line. Southern Tide's Christopher Heyn joins us to discuss the preppy look's national appeal. He thinks the uptick in popularity can be attributed to consumers learning what the South is all about.
As one of the fastest-growing brands in the country, Southern Tide is finding new ways to compete in a crowded retail landscape. Heyn says he wakes up "a little worried" every day about the changing landscape for brick-and-mortar retail outlets. Despite the concern, he tells us why the company is investing in more signature locations around the country.
Finally, Heyn discusses the importance of branded partnerships to his company's success. He describes Southern Tide's relationships with Ocearch and Folds of Honor. These organizations don't just achieve marketing goals, they also fall in line with the brand's beliefs and values.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
